"Chondrocalcinosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.
| Descriptor ID |
D002805
|
| MeSH Number(s) |
C05.550.114.264 C05.550.354.125
|
| Concept/Terms |
Chondrocalcinosis- Chondrocalcinosis
- Chondrocalcinoses
- Pseudogout
- Calcium Pyrophosphate Deposition Disease
|
Below are MeSH descriptors whose meaning is more general than "Chondrocalcinosis".
Below are MeSH descriptors whose meaning is more specific than "Chondrocalcinosis".
This graph shows the total number of publications written about "Chondrocalcinosis" by people in this website by year, and whether "Chondrocalcinosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chondrocalcinosis" by people in Profiles.
-
Chondrocalcinosis Under Diagnostic Ultrasound in a Recreational Tennis Player. Am J Phys Med Rehabil. 2022 10 01; 101(10):e151-e152.
-
Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab. J Immunother Cancer. 2021 07; 9(7).
-
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 08; 51(4):946-950.
-
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 06; 51(3):655-660.
-
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 06; 51(3):650-654.
-
Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group. Semin Arthritis Rheum. 2020 08; 50(4):719-727.
-
Heterotopic ossification: radiological and pathological review. Radiol Oncol. 2019 09 24; 53(3):275-284.
-
Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare. J Immunother Cancer. 2019 05 14; 7(1):126.
-
Validation of administrative codes for calcium pyrophosphate deposition: a Veterans Administration study. J Clin Rheumatol. 2015 Jun; 21(4):189-92.
-
Is the double contour sign specific for gout? Or only for crystal arthritis? J Rheumatol. 2015 Mar; 42(3):353-4.